AIMD Ainos, Inc.: Prakiraan wutah bathi kanggo taun ngarep

Simbol lan logo merek Ainos Corp (AIMD)

Ainos, Inc. develops advanced tests for detecting cancer and respiratory pathologies, expanding its presence in the Point-of-Care segment. The forward net income growth rate reflects market expectations, where 0.00 shows the current value of the metric. Ainos, Inc. generates revenue from AI-driven rapid diagnostic systems, and its position is protected by patents and stringent FDA accuracy standards for research.

AIMD: Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Ainos Corp 28.04.2023 - 15.11.2026

Rincian metrik lan analitis perusahaan Ainos Inc (AIMD)

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:Ainos, Inc.
Barang utama Ainos

This indicator measures the expected earnings per share (EPS) growth for the following year, reflecting the analysts' consensus forecast regarding the business's fundamental maturity. By analyzing the forward-looking EPS n+1 growth rate, an investor can assess cash flow stability or the risk of missed opportunities during a trend reversal. For Ainos, Inc. (AIMD), this metric is critical as it reflects the success of its expansion into the US market and the efficiency of its AI platform licensing.

Analisis pesaing Ainos, Inc.

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|XGN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDxHealth Inc. - Proyeksi tambahing bathi saben saham ing taun ngarep|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Prenetics Global Limited - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRPH|Proyeksi tambahing bathi saben saham ing taun ngarep CODX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heart Test Laboratories HSCS|BMRA: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|CDIO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Onconetix Corp (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VRAX (Virax Biolabs Group Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep